Topiramate
978-613-0-89969-1
6130899696
140
2010-07-19
45,00 €
eng
https://images.our-assets.com/cover/230x230/9786130899691.jpg
https://images.our-assets.com/fullcover/230x230/9786130899691.jpg
https://images.our-assets.com/cover/2000x/9786130899691.jpg
https://images.our-assets.com/fullcover/2000x/9786130899691.jpg
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Topiramate (brand name Topamax) is an anticonvulsant drug produced by Ortho-McNeil Neurologics and Noramco, Inc., both divisions of Johnson & Johnson. It was discovered in 1979 by Bruce E. Maryanoff and Joseph F. Gardocki during their research work at McNeil Pharmaceutical. Generic versions are available in Canada and were FDA approved in September 2006. Mylan Pharmaceuticals was recently granted final approval for generic topiramate 25, 100, and 200 mg tablets and sprinkle capsules by the FDA for sale in the US. 50 mg tablets were granted tentative approval.The last patent for topiramate in the U.S. was for pediatric use; this patent expired on February 28, 2009.
https://morebooks.de/books/hu/published_by/betascript-publishing/1/products
Gyógyszerészet
https://morebooks.de/store/hu/book/topiramate/isbn/978-613-0-89969-1